Maman Biomedical
Maman Biomedical is a privately held company based in Toronto, Ontario, focused on developing innovative drug delivery solutions to improve fertility treatments. Founded in 2024, the company aims to reduce the pain and inconvenience associated with current fertility therapies through its proprietary gels and patches.
Company Overview
Maman Biomedical is a privately held company founded in 2024, headquartered in Toronto, Ontario, Canada. The company operates within the Pharmaceutical Manufacturing industry and is classified as a very small business with a team size of six. Maman Biomedical focuses on creating disruptive interventions aimed at redefining the current status quo of fertility treatments. The company emphasizes alleviating pain and nurturing families through innovative solutions.
Innovative Products
Maman Biomedical is developing proprietary controlled-release therapeutic gels and patches designed to deliver fertility drugs. The Maman Gel offers a significant reduction in injections, providing a 90% decrease compared to current standard care. The Maman Patch serves as a premium pain-free alternative for needle-free fertility treatment, while the Maman Port is an adhesive patch that complements existing fertility treatment regimens to minimize the burden of daily injections. These products aim to address the pain and inconvenience reported by individuals undergoing fertility treatments.
Funding and Financial Growth
Maman Biomedical has successfully raised $250,000 in a Friends and Family funding round, which was over-subscribed. The company has also tripled its early funding through non-dilutive means. Prior to its hard launch, Maman Biomedical raised an additional $250,000, with 52% of the round already soft-committed. This financial backing supports the development of its innovative fertility treatment solutions.
Specialties and Research Focus
Maman Biomedical specializes in various fields including IVF research, biotechnology, medical devices, drug delivery, fertility, and materials science. The company operates at the interface of materials science and drug therapeutics, focusing on creating solutions that alleviate the pain and trauma associated with fertility treatments. Up to 78% of individuals undergoing such treatments report negative experiences, which Maman Biomedical aims to improve through its innovative products.
Social Media Presence
Maman Biomedical has cultivated an organic social media presence, reaching 500 users. This growth reflects the company's commitment to engaging with its audience and raising awareness about its innovative fertility treatment solutions. The social media strategy supports the company's mission to alleviate pain and enhance the fertility treatment experience for families.